What is the appropriate pediatric dose of amoxicillin‑clavulanate (Augmentin)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pediatric Augmentin Dosing

For β-lactamase-producing organisms (such as β-lactamase-producing Haemophilus influenzae or Moraxella catarrhalis), use amoxicillin-clavulanate at 45 mg/kg/day (of the amoxicillin component) divided into 3 doses, or 90 mg/kg/day divided into 2 doses 1, 2, 1.

Standard Dosing Regimens

For β-Lactamase-Producing Pathogens

The IDSA/PIDS pediatric pneumonia guidelines specify two acceptable dosing options for oral amoxicillin-clavulanate when treating β-lactamase-producing organisms 1, 2, 1:

  • 45 mg/kg/day in 3 divided doses (15 mg/kg per dose)
  • 90 mg/kg/day in 2 divided doses (45 mg/kg per dose)

Both regimens refer to the amoxicillin component of the combination.

High-Dose Formulation (Augmentin ES-600)

For more severe infections or when enhanced coverage is needed, Augmentin ES-600 provides 90 mg/kg/day divided every 12 hours 3. This formulation contains 600 mg amoxicillin/42.9 mg clavulanate per 5 mL and is specifically designed for:

  • Persistent or recurrent acute otitis media
  • Risk factors for drug-resistant S. pneumoniae
  • β-lactamase-producing organisms

The FDA label specifies this is for pediatric patients ≥3 months old, with dosing based on weight 3:

  • 8 kg: 3.0 mL twice daily
  • 12 kg: 4.5 mL twice daily
  • 16 kg: 6.0 mL twice daily
  • 20 kg: 7.5 mL twice daily

Clinical Context and Considerations

When to Use Standard vs. High-Dose

Use standard-dose (45 mg/kg/day in 3 doses) for:

  • Mild to moderate infections
  • Children ≥2 years old
  • No recent antibiotic exposure (<4 weeks)
  • Not attending daycare

Use high-dose (90 mg/kg/day in 2 doses) for 4:

  • Moderate to severe illness
  • Children <2 years old
  • Recent antibiotic exposure (within 30 days)
  • Daycare attendance
  • High local prevalence of β-lactamase-producing H. influenzae

Important Caveats

Do not exceed adult doses - the guidelines explicitly state that pediatric oral therapy doses should not exceed standard adult dosing 1, 2, 1.

Clavulanate content varies - Different Augmentin formulations contain different amounts of clavulanate. The ES-600 formulation (42.9 mg/5 mL) is NOT interchangeable with standard suspensions (200 mg/5 mL contains 28.5 mg clavulanate; 400 mg/5 mL contains 57 mg clavulanate) 3.

Gastrointestinal side effects - Diarrhea is the most common adverse effect, occurring in approximately 17-26% of children 5. The high-dose formulation may cause more GI disturbances, though recent evidence suggests lower clavulanate concentrations (2.85-3.2 mg/kg/day) may reduce diarrhea rates without compromising efficacy 5.

Administration

Give at the start of meals to minimize GI intolerance and enhance clavulanate absorption 3. The reconstituted suspension is stable for 10 days under refrigeration. Shake well before each use.

Duration of Therapy

Treat for 10 days for most respiratory infections 1, 2, 1. This is the best-studied duration, though shorter courses may be effective for milder disease managed outpatient.

Special Populations

Critically ill children may require more frequent dosing (every 4 hours instead of every 6 hours) due to augmented renal clearance, particularly post-cardiac surgery or in sepsis 6, 7. Standard dosing often results in subtherapeutic levels in this population.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.